Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kevin Diep"'
Autor:
Albitar F, Kevin Diep, S. Agersborg, Wanlong Ma, De Dios I, Maher Albitar, S. Brodie, M. Thangavelu
Publikováno v:
Genetic Testing and Molecular Biomarkers. 20:341-345
Demonstrating the presence of myelodysplastic syndrome (MDS)-specific molecular abnormalities can aid in diagnosis and patient management. We explored the potential of using peripheral blood (PB) cell-free DNA (cf-DNA) and next-generation sequencing
Publikováno v:
Integrative Obesity and Diabetes. 4
Publikováno v:
Integrative Obesity and Diabetes. 3
Publikováno v:
Genetic Testing and Molecular Biomarkers. 18:156-163
To avoid relying solely on serum prostate-specific antigen (sPSA) in screening for prostate cancer (PCa), we developed a scoring system for detecting PCa and the prediction of aggressiveness. We analyzed urine and plasma specimens from 121 patients w
Autor:
Wanlong Ma, Maya Thangavelu, Ivan De Dios, Sally Agersborg, Steve Brodie, Maher Albitar, Kevin Diep, Ferras Albitar
Publikováno v:
Blood. 124:1909-1909
Background: In patients presenting with cytopenia, myelodysplastic syndrome (MDS) should be considered, but confirmation of diagnosis requires bone marrow biopsy and morphologic and cytogenetic evaluation. It is extremely difficult to rely on subject
Publikováno v:
Journal of Clinical Oncology. 32:e16026-e16026
e16026 Background: We have previously reported algorithms which combine urine and plasma biomarkers to provide diagnostic information regarding a decision to perform a prostate biopsy and biologic ...
Publikováno v:
Journal of Clinical Oncology. 32:163-163
163 Background: Relying solely on serum prostate-specific antigen (sPSA) to screen for prostate cancer (PCa) can lead to unnecessary biopsies. Biomarkers from urine and plasma were isolated to develop a detection scoring system for the presence of pr